Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity

Cancer immunotherapy has emerged as a promising therapeutic intervention. However, complete and durable responses are only seen in a fraction of patients who have cancer. A key factor that limits therapeutic success is the infiltration of tumors by cells of the myeloid lineage. The inhibitory recept...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Proc Natl Acad Sci U S A
Autori principali: Ring, Nan Guo, Herndler-Brandstetter, Dietmar, Weiskopf, Kipp, Shan, Liang, Volkmer, Jens-Peter, George, Benson M., Lietzenmayer, Melanie, McKenna, Kelly M., Naik, Tejaswitha J., McCarty, Aaron, Zheng, Yunjiang, Ring, Aaron M., Flavell, Richard A., Weissman, Irving L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: National Academy of Sciences 2017
Soggetti:
PNAS Plus
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5724266/
https://ncbi.nlm.nih.gov/pubmed/29158380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1710877114
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi